Availability of human induced pluripotent stem cell-derived cardiomyocytes in assessment of drug potential for QT prolongation .
O O B-OrganismTaxon O O O O O O O O O O O B-DiseaseOrPhenotypicFeature I-DiseaseOrPhenotypicFeature O